-
公开(公告)号:US20230181472A1
公开(公告)日:2023-06-15
申请号:US17283068
申请日:2019-10-29
申请人: Amgen Inc.
CPC分类号: A61K9/1694 , A61K31/55 , A61K9/1623 , A61K9/1652 , A61K9/1617 , A61K9/1611 , A61K9/2018 , A61K9/2059 , A61K9/2013 , A61K9/2009 , A61K9/2095 , A61K9/2893 , A61K9/284
摘要: A new process for making ivabradine hydrochloride drug product reduces the amount of amorphous ivabradine hydrochloride in the drug product.